Detalhe da pesquisa
1.
Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial.
Ann Rheum Dis
; 83(3): 351-359, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123922
2.
Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Kidney Int Rep
; 9(6): 1783-1791, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38899183
3.
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19.
Sci Transl Med
; 15(724): eadh4529, 2023 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019932
4.
A20/TNFAIP3 Increases ENOS Expression in an ERK5/KLF2-Dependent Manner to Support Endothelial Cell Health in the Face of Inflammation.
Front Cardiovasc Med
; 8: 651230, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34026871
5.
Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan.
RMD Open
; 9(3)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640515